Quantcast

Latest Genetic testing Stories

2014-07-31 23:07:50

First in the Series, “ClariView Exome for Neurology” Test to Address Pediatric Neurological Disorders Cambridge, MA (PRWEB) July 31, 2014 Claritas Genomics, a clinical laboratory serving the DNA-based diagnostic testing needs of children’s hospitals, announced today that it is launching a novel series of clinical assays that combine the flexibility and comprehensiveness of whole exome sequencing with the rigor of deep and focused analysis of variants associated with specific...

2014-07-31 12:29:39

Investment from Blue Cross Blue Shield of Massachusetts subsidiary will strengthen genetic benefits services ST. PETERSBURG, Fla., July 31, 2014 /PRNewswire-USNewswire/ -- InformedDNA, a leading provider of Genetic Benefits Management and the largest independent network of genetic specialists in the U.S., announced today that it has reached a $4.5 million funding agreement with Zaffre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts. InformedDNA will...

2014-07-31 08:36:56

-- Panorama NIPT technology significantly reduces the number of false positives compared to quantitative NIPTs -- SAN CARLOS, Calif., July 31, 2014 /PRNewswire/ -- Natera, Inc., a leader in non-invasive genetic testing, today announced a study published in the August issue of Obstetrics and Gynecology, which demonstrates that the Panorama non-invasive prenatal test (NIPT) performs consistently well in all pregnant women, regardless of their prior risk level. This is the first major...

2014-07-22 08:31:04

Initial Target of the Parabase Sequencing Service is the Neonatal Intensive Care Unit of U.S. Hospitals with the Goal of Improving Early Diagnosis of Genetic Diseases SOUTH EASTON, Mass., July 22, 2014 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") and Parabase Genomics ("Parabase"), (together "the companies"), today announced they have entered into a strategic research and development agreement (the "collaboration"). Under the terms of the...

2014-07-14 08:26:01

SAN DIEGO, July 14, 2014 /PRNewswire/ -- Diomics, Inc., provider of X-Swab(TM), a novel bio-specimen collection material, today announced that the United States Patent and Trademark Office has issued two U.S. Patents held by Diomics covering novel biologic sample collection materials, devices made from them, and methods for their use in forensics and diagnostics. The primary method of collecting forensic stain materials is by swabbing. Recovery of DNA from a number of...

2014-07-10 12:31:08

Genetic Testing Service Designed to Detect Genetic Variants Linked to Autism Spectrum Disorders and Other Disorders of Childhood Development PROVO, Utah, July 10, 2014 /PRNewswire-iReach/ -- Tute Genomics, the leader in genome annotation and interpretation, today announced an agreement with Lineagen, Inc., to provide next-generation sequencing (NGS) analytics for Lineagen's NextStep(Dx) PLUS. Lineagen, focused on the diagnostic evaluation of neurodevelopmental and neurological...

2014-07-10 08:29:24

Aims to provide evidence-based information to reduce misuse of genetic testing ST. PETERSBURG, Fla., July 10, 2014 /PRNewswire-USNewswire/ -- InformedDNA, the largest independent provider of genetic counseling services, released today a white paper that provides clarity on the appropriate use of genetic testing. Use of these diagnostic tests is growing rapidly, but inappropriate testing has negative consequences for individuals and the U.S. health care system. The paper, titled Genetic...

2014-07-07 04:20:59

COPENHAGEN, July 7, 2014 /PRNewswire/ -- BGI Diagnostics' NIFTY(TM) test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA). On June 30, 2014, the CFDA approved the registration of BGI's BGISEQ-1000 and BGISEQ-100 sequencers, and its prenatal genetic testing kits for NIFTY(TM) (Non-Invasive Fetal Trisomy test). This is the first genetic test based on next generation sequencing technology to...

2014-06-30 23:10:07

Hayes, Inc. experts demonstrate how to apply information to create defensible coverage policies. Lansdale, PA (PRWEB) June 30, 2014 Reviewing the medical need for genetic tests and writing coverage policies for these complex assays and conditions can be a daunting task. Creating defensible coverage policies becomes more challenging when the evidence is limited and inconclusive. Translating Limited and Inconclusive Evidence about Genetic Tests into Coverage Policy, a webinar hosted by...

2014-06-25 23:14:27

AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June 25, 2014 Advances in genetic testing technology have improved detection rates for BRCA1 and BRCA2 mutations in individuals who are at high risk for breast and ovarian cancer, but some mutations are missed with standard genetic testing. During a recent AllMed webinar, Dr. Della Howell, board-certified hematologist-oncologist,...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related